Annual EBIT
-$15.32 M
-$10.01 M-188.86%
31 December 2023
Summary:
Carmell Therapeutics Corporatio annual earnings before interest & taxes is currently -$15.32 million, with the most recent change of -$10.01 million (-188.86%) on 31 December 2023. During the last 3 years, it has fallen by -$11.34 million (-284.84%). CTCX annual EBIT is now -284.84% below its all-time high of -$3.74 million.CTCX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$2.87 M
+$423.80 K+12.86%
30 September 2024
Summary:
Carmell Therapeutics Corporatio quarterly earnings before interest & taxes is currently -$2.87 million, with the most recent change of +$423.80 thousand (+12.86%) on 30 September 2024. Over the past year, it has dropped by -$2.88 million (-22709.45%). CTCX quarterly EBIT is now -22709.45% below its all-time high of $12.70 thousand, reached on 31 December 2023.CTCX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$9.68 M
+$5.86 M+37.70%
30 September 2024
Summary:
Carmell Therapeutics Corporatio TTM earnings before interest & taxes is currently -$9.68 million, with the most recent change of +$5.86 million (+37.70%) on 30 September 2024. Over the past year, it has increased by +$5.63 million (+36.78%). CTCX TTM EBIT is now -3286.50% below its all-time high of -$285.90 thousand, reached on 30 June 2022.CTCX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTCX EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -10000.0% | +36.8% |
| 3 y3 years | -284.8% | - | - |
| 5 y5 years | - | - | - |
CTCX EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -284.8% | at low | <-9999.0% | +67.1% | -3286.5% | +46.6% |
| 5 y | 5 years | -284.8% | at low | <-9999.0% | +67.1% | -3286.5% | +46.6% |
| alltime | all time | -284.8% | at low | <-9999.0% | +67.1% | -3286.5% | +46.6% |
Carmell Therapeutics Corporatio EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.87 M(-12.9%) | -$9.68 M(-37.7%) |
| June 2024 | - | -$3.30 M(-6.6%) | -$15.54 M(-10.1%) |
| Mar 2024 | - | -$3.53 M(<-9900.0%) | -$17.28 M(+12.8%) |
| Dec 2023 | -$15.32 M | $12.70 K(-100.1%) | -$15.32 M(-15.5%) |
| Sept 2023 | - | -$8.73 M(+73.5%) | -$18.12 M(+29.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$5.03 M(+221.5%) | -$13.96 M(+51.5%) |
| Mar 2023 | - | -$1.57 M(-43.9%) | -$9.21 M(+20.5%) |
| Dec 2022 | -$5.30 M(+33.2%) | -$2.79 M(-39.1%) | -$7.65 M(+57.4%) |
| Sept 2022 | - | -$4.57 M(+1500.2%) | -$4.86 M(+1600.2%) |
| June 2022 | - | -$285.90 K | -$285.90 K |
| Dec 2021 | -$3.98 M | - | - |
FAQ
- What is Carmell Therapeutics Corporatio annual earnings before interest & taxes?
- What is the all time high annual EBIT for Carmell Therapeutics Corporatio?
- What is Carmell Therapeutics Corporatio quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Carmell Therapeutics Corporatio?
- What is Carmell Therapeutics Corporatio quarterly EBIT year-on-year change?
- What is Carmell Therapeutics Corporatio TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Carmell Therapeutics Corporatio?
- What is Carmell Therapeutics Corporatio TTM EBIT year-on-year change?
What is Carmell Therapeutics Corporatio annual earnings before interest & taxes?
The current annual EBIT of CTCX is -$15.32 M
What is the all time high annual EBIT for Carmell Therapeutics Corporatio?
Carmell Therapeutics Corporatio all-time high annual earnings before interest & taxes is -$3.74 M
What is Carmell Therapeutics Corporatio quarterly earnings before interest & taxes?
The current quarterly EBIT of CTCX is -$2.87 M
What is the all time high quarterly EBIT for Carmell Therapeutics Corporatio?
Carmell Therapeutics Corporatio all-time high quarterly earnings before interest & taxes is $12.70 K
What is Carmell Therapeutics Corporatio quarterly EBIT year-on-year change?
Over the past year, CTCX quarterly earnings before interest & taxes has changed by -$2.88 M (-22709.45%)
What is Carmell Therapeutics Corporatio TTM earnings before interest & taxes?
The current TTM EBIT of CTCX is -$9.68 M
What is the all time high TTM EBIT for Carmell Therapeutics Corporatio?
Carmell Therapeutics Corporatio all-time high TTM earnings before interest & taxes is -$285.90 K
What is Carmell Therapeutics Corporatio TTM EBIT year-on-year change?
Over the past year, CTCX TTM earnings before interest & taxes has changed by +$5.63 M (+36.78%)